156 related articles for article (PubMed ID: 37925068)
41. Improvements in the Management of Patients With Generalized Pustular Psoriasis in Spain: Recommendations From a Group of Experts.
Rivera-Díaz R; Carrascosa Carrillo JM; Alfonso Zamora S; Navarro Valdivieso JP; Muñoz Cabello B; Ros Abarca S; de Francisco JMS; Daudén Tello E
Actas Dermosifiliogr; 2024 Jul; ():. PubMed ID: 38972580
[TBL] [Abstract][Full Text] [Related]
42. Spesolimab for the Treatment of Generalized Pustular Psoriasis.
Bernardo D; Thaçi D; Torres T
Drugs; 2024 Jan; 84(1):45-58. PubMed ID: 38114719
[TBL] [Abstract][Full Text] [Related]
43. [Psoriasis in children and adolescents. A nationwide physician survey on the healthcare situation in Germany].
Matusiewicz D; Körber A; Schadendorf D; Wasem J; Neumann A
Hautarzt; 2012 Oct; 63(10):801-7. PubMed ID: 23008005
[TBL] [Abstract][Full Text] [Related]
44. Evaluating practice patterns for managing moderate to severe plaque psoriasis: role of the family physician.
Poulin Y; Wasel N; Chan D; Bernstein G; Andrew R; Fraquelli E; Papp K
Can Fam Physician; 2012 Jul; 58(7):e390-400. PubMed ID: 22859642
[TBL] [Abstract][Full Text] [Related]
45. Treatment Options and Goals for Patients with Generalized Pustular Psoriasis.
Krueger J; Puig L; Thaçi D
Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):51-64. PubMed ID: 35061230
[TBL] [Abstract][Full Text] [Related]
46. Consensus document on the evaluation and treatment of moderate-to-severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology.
Daudén E; Puig L; Ferrándiz C; Sánchez-Carazo JL; Hernanz-Hermosa JM;
J Eur Acad Dermatol Venereol; 2016 Mar; 30 Suppl 2():1-18. PubMed ID: 26812550
[TBL] [Abstract][Full Text] [Related]
47. SARS-CoV-19 and Generalised Pustular Psoriasis: A Lethal Combination.
Narang T; Sharma A; Bhandari A; Handa S; Dogra S
Indian J Dermatol; 2023; 68(6):726. PubMed ID: 38371580
[TBL] [Abstract][Full Text] [Related]
48. Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era?
Megna M; Camela E; Ruggiero A; Battista T; Martora F; Cacciapuoti S; Potestio L
Clin Cosmet Investig Dermatol; 2023; 16():1677-1690. PubMed ID: 37404368
[TBL] [Abstract][Full Text] [Related]
49. Regional differences in the prevalence of generalized pustular psoriasis in Japan.
Fujita H; Iwasaki R; Tsuboi S; Murashiuma Y; Akiyama M
J Dermatol; 2024 Mar; 51(3):380-390. PubMed ID: 38292005
[TBL] [Abstract][Full Text] [Related]
50. Psoriasis of early and late onset: a clinical and epidemiologic study from Spain.
Ferrándiz C; Pujol RM; García-Patos V; Bordas X; Smandía JA
J Am Acad Dermatol; 2002 Jun; 46(6):867-73. PubMed ID: 12063483
[TBL] [Abstract][Full Text] [Related]
51. Improvements in the Management of Patients With Generalized Pustular Psoriasis in Spain: Recommendations From a Group of Experts.
Rivera-Díaz R; Carrascosa Carrillo JM; Alfonso Zamora S; Navarro Valdivieso JP; Muñoz Cabello B; Ros Abarca S; Soria de Francisco JM; Daudén Tello E
Actas Dermosifiliogr; 2024 May; ():. PubMed ID: 38777227
[TBL] [Abstract][Full Text] [Related]
52. Management of childhood psoriasis in France. A national survey among general practitioners, pediatricians, and dermatologists.
Mahé E; Bursztejn AC; Phan A; Corgibet F; Beauchet A
Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29193624
[TBL] [Abstract][Full Text] [Related]
53. Current practice of methotrexate use for psoriasis: results of a worldwide survey among dermatologists.
Gyulai R; Bagot M; Griffiths CEM; Luger T; Naldi L; Paul C; Puig L; Kemény L
J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):224-231. PubMed ID: 24731093
[TBL] [Abstract][Full Text] [Related]
54. Juvenile generalized pustular psoriasis is a chronic recalcitrant disease: an analysis of 27 patients seen in a tertiary hospital in Johor, Malaysia.
Lau BW; Lim DZ; Capon F; Barker JN; Choon SE
Int J Dermatol; 2017 Apr; 56(4):392-399. PubMed ID: 28194751
[TBL] [Abstract][Full Text] [Related]
55. Exploring the Clinical Assessment, Guidelines, and Options for the Treatment of Generalized Pustular Psoriasis [Podcast].
Song EJ; Liu C
Clin Cosmet Investig Dermatol; 2023; 16():2911-2917. PubMed ID: 37915421
[TBL] [Abstract][Full Text] [Related]
56. Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare.
Choon SE; Lebwohl MG; Marrakchi S; Burden AD; Tsai TF; Morita A; Navarini AA; Zheng M; Xu J; Turki H; Rajeswari S; Deng H; Tetzlaff K; Thoma C; Bachelez H
BMJ Open; 2021 Mar; 11(3):e043666. PubMed ID: 33785490
[TBL] [Abstract][Full Text] [Related]
57. The Prevalence and Disease Characteristics of Generalized Pustular Psoriasis.
Zheng M; Jullien D; Eyerich K
Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):5-12. PubMed ID: 35061224
[TBL] [Abstract][Full Text] [Related]
58. Patient characteristics and burden of disease in Japanese patients with generalized pustular psoriasis: Results from the Medical Data Vision claims database.
Morita A; Kotowsky N; Gao R; Shimizu R; Okubo Y
J Dermatol; 2021 Oct; 48(10):1463-1473. PubMed ID: 34212422
[TBL] [Abstract][Full Text] [Related]
59. International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis Council.
Choon SE; van de Kerkhof P; Gudjonsson JE; de la Cruz C; Barker J; Morita A; Romiti R; Affandi AM; Asawanonda P; Burden AD; Gonzalez C; Marrakchi S; Mowla MR; Okubo Y; Oon HH; Terui T; Tsai TF; Callis-Duffin K; Fujita H; Jo SJ; Merola J; Mrowietz U; Puig L; Thaçi D; Velásquez M; Augustine M; El Sayed M; Navarini AA; Pink A; Prinz J; Turki H; Magalhães R; Capon F; Bachelez H;
JAMA Dermatol; 2024 May; ():. PubMed ID: 38691347
[TBL] [Abstract][Full Text] [Related]
60. Exploring the Clinical Features, Immunopathogenesis and Approach to Diagnosis for Generalized Pustular Psoriasis [Podcast].
Bhutani T; Hawkes JE
Clin Cosmet Investig Dermatol; 2023; 16():1553-1558. PubMed ID: 37351064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
